Koers Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aandelen
6990
CNE1000062J1
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
168 HKD | +9,16% | +23,17% | +63,27% |
Omzet 2024 * | 1,16 mld. 160 mln. 1,25 mld. 149 mln. | Omzet 2025 * | 1,49 mld. 205 mln. 1,61 mld. 192 mln. | Marktkapitalisatie | 34,09 mld. 4,7 mld. 36,83 mld. 4,4 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -625 mln. -86,26 mln. -675 mln. -80,67 mln. | Nettowinst (verlies) 2025 * | -684 mln. -94,4 mln. -739 mln. -88,29 mln. | EV/omzet 2024 * | 29 x |
Nettoliquiditeiten 2024 * | 464 mln. 64,07 mln. 502 mln. 59,92 mln. | Nettoliquiditeiten 2025 * | 639 mln. 88,21 mln. 690 mln. 82,5 mln. | EV/omzet 2025 * | 22,5 x |
K/w-verhouding 2024 * |
-52,4
x | K/w-verhouding 2025 * |
-48,3
x | Werknemers | 1.446 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 55,25% |
1 dag | +9,16% | ||
1 week | +23,17% | ||
Lopende maand | +8,39% | ||
1 maand | +13,36% | ||
3 maanden | +98,82% | ||
6 maanden | +118,32% | ||
Lopend jaar | +63,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jun You Ge
CEO | Chief Executive Officer | 51 | 08-02-21 |
Ze Jian Zhou
DFI | Director of Finance/CFO | 41 | 25-02-22 |
Xiang Yang Tan
CTO | Chief Tech/Sci/R&D Officer | 61 | 05-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ge Xin Liu
FOU | Founder | 73 | 22-11-16 |
Si Chuan Liu
BRD | Director/Board Member | 40 | 22-11-16 |
Hao Feng
BRD | Director/Board Member | 44 | 12-02-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 168 | +9,16% | 484 184 |
25-04-24 | 153,9 | -0,06% | 318 406 |
24-04-24 | 154 | +4,19% | 441 724 |
23-04-24 | 147,8 | +5,95% | 350 500 |
22-04-24 | 139,5 | +2,27% | 291 700 |
uitgestelde koers Hong Kong S.E., 26 april 2024 om 10:08 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+63,27% | 4,7 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |